▶ 調査レポート

世界の炎症性腸疾患（IBD）の治療市場：市場規模・現状・予測
• 英文タイトル：Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の炎症性腸疾患（IBD）の治療市場：市場規模・現状・予測 / Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7362資料のイメージです。• レポートコード：QYR9N7362
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、炎症性腸疾患（IBD）の治療のグローバル市場について調査・分析したレポートで、種類別（TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・炎症性腸疾患（IBD）の治療の世界市場規模
・主要企業別市場シェア
・炎症性腸疾患（IBD）の治療の世界市場規模：種類別（TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド）
・炎症性腸疾患（IBD）の治療の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局）
・炎症性腸疾患（IBD）の治療のアメリカ市場規模（種類別、用途別）
・炎症性腸疾患（IBD）の治療のヨーロッパ市場規模（種類別、用途別）
・炎症性腸疾患（IBD）の治療の中国市場規模（種類別、用途別）
・炎症性腸疾患（IBD）の治療の日本市場規模（種類別、用途別）
・炎症性腸疾患（IBD）の治療の東南アジア市場規模（種類別、用途別）
・炎症性腸疾患（IBD）の治療のインド市場規模（種類別、用途別）
・炎症性腸疾患（IBD）の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・炎症性腸疾患（IBD）の治療の世界市場予測（2019年-2025年）
・炎症性腸疾患（IBD）の治療の地域別市場予測（2019年-2025年）
...

Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes the inflammation sores in the inner lining of colon and rectum. The Crohn’s disease affects any part of gastrointestinal tract and unlike ulcerative colitis, it affects all the layers of gastrointestinal walls. The ulcerative colitis is more prevalent than that of Crohn’s disease. The IBD affects equally in men and women and has prevalence and incidence rates in developed countries than that of developing and under developed countries. The exact cause of inflammatory bowel disease are not well understood however, the combination of several factors such as autoimmune disorders, genetic factors, lifestyle related risks factors such as smoking, sedentary lifestyle, lack of exercise are likely to contribute to the development of symptoms of inflammatory bowel disease. The common symptoms of inflammatory bowel disease includes the severe abdominal cramps and pain, persistent diarrhea, occasional rectal bleeding. The IBD has no permanent cure and requires the lifelong disease management and treatment. Several medications such as corticosteroids, aminosalicyclates, immunomodulators, and biologic drugs such as TNF inhibitors and up to certain extent antibiotic drugs are prescribed to relive the symptoms of these diseases.
In 2018, the global Inflammatory Bowel Disease (IBD) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Inflammatory Bowel Disease (IBD) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Bowel Disease (IBD) Treatment development in United States, Europe and China.

The key players covered in this study
AbbVie
Pfizer
Shire Plc
Janssen Biotech, Inc. (Johnson & Johnson)
Allergan
Valeant Pharmaceuticals
Takeda Pharmaceutical
Novartis
Biogen Inc.

Market segment by Type, the product can be split into
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Corticosteroids

Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Inflammatory Bowel Disease (IBD) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Inflammatory Bowel Disease (IBD) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Inflammatory Bowel Disease (IBD) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 TNF Inhibitors
1.4.3 Aminosalicyclates
1.4.4 Immunomodulators
1.4.5 Corticosteroids
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Inflammatory Bowel Disease (IBD) Treatment Market Size
2.2 Inflammatory Bowel Disease (IBD) Treatment Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions (2014-2025)
2.2.2 Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Inflammatory Bowel Disease (IBD) Treatment Market Size by Manufacturers
3.1.1 Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Inflammatory Bowel Disease (IBD) Treatment Key Players Head office and Area Served
3.3 Key Players Inflammatory Bowel Disease (IBD) Treatment Product/Solution/Service
3.4 Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2014-2019)
4.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Inflammatory Bowel Disease (IBD) Treatment Market Size (2014-2019)
5.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in United States
5.3 United States Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
5.4 United States Inflammatory Bowel Disease (IBD) Treatment Market Size by Application

6 Europe
6.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size (2014-2019)
6.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Europe
6.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
6.4 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application

7 China
7.1 China Inflammatory Bowel Disease (IBD) Treatment Market Size (2014-2019)
7.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in China
7.3 China Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
7.4 China Inflammatory Bowel Disease (IBD) Treatment Market Size by Application

8 Japan
8.1 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size (2014-2019)
8.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Japan
8.3 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
8.4 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size (2014-2019)
9.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
9.4 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Application

10 India
10.1 India Inflammatory Bowel Disease (IBD) Treatment Market Size (2014-2019)
10.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in India
10.3 India Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
10.4 India Inflammatory Bowel Disease (IBD) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size (2014-2019)
11.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Central & South America
11.3 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type
11.4 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application

12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Inflammatory Bowel Disease (IBD) Treatment Introduction
12.1.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
12.1.5 AbbVie Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Inflammatory Bowel Disease (IBD) Treatment Introduction
12.2.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Shire Plc
12.3.1 Shire Plc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Inflammatory Bowel Disease (IBD) Treatment Introduction
12.3.4 Shire Plc Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
12.3.5 Shire Plc Recent Development
12.4 Janssen Biotech, Inc. (Johnson & Johnson)
12.4.1 Janssen Biotech, Inc. (Johnson & Johnson) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Inflammatory Bowel Disease (IBD) Treatment Introduction
12.4.4 Janssen Biotech, Inc. (Johnson & Johnson) Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
12.4.5 Janssen Biotech, Inc. (Johnson & Johnson) Recent Development
12.5 Allergan
12.5.1 Allergan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Inflammatory Bowel Disease (IBD) Treatment Introduction
12.5.4 Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
12.5.5 Allergan Recent Development
12.6 Valeant Pharmaceuticals
12.6.1 Valeant Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Inflammatory Bowel Disease (IBD) Treatment Introduction
12.6.4 Valeant Pharmaceuticals Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
12.6.5 Valeant Pharmaceuticals Recent Development
12.7 Takeda Pharmaceutical
12.7.1 Takeda Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Inflammatory Bowel Disease (IBD) Treatment Introduction
12.7.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
12.7.5 Takeda Pharmaceutical Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Inflammatory Bowel Disease (IBD) Treatment Introduction
12.8.4 Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Biogen Inc.
12.9.1 Biogen Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Inflammatory Bowel Disease (IBD) Treatment Introduction
12.9.4 Biogen Inc. Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
12.9.5 Biogen Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Inflammatory Bowel Disease (IBD) Treatment Key Market Segments
Table Key Players Inflammatory Bowel Disease (IBD) Treatment Covered
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Type 2014-2025
Figure TNF Inhibitors Figures
Table Key Players of TNF Inhibitors
Figure Aminosalicyclates Figures
Table Key Players of Aminosalicyclates
Figure Immunomodulators Figures
Table Key Players of Immunomodulators
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacy Case Studies
Figure Retail Pharmacy Case Studies
Figure Online Pharmacy Case Studies
Figure Inflammatory Bowel Disease (IBD) Treatment Report Years Considered
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size 2014-2025 (Million US$)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Manufacturers in 2018
Table Global Inflammatory Bowel Disease (IBD) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Inflammatory Bowel Disease (IBD) Treatment Product/Solution/Service
Table Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Type (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Type (2014-2019)
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Application (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Application in 2018
Figure United States Inflammatory Bowel Disease (IBD) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2018-2019)
Table United States Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2014-2019)
Table United States Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2014-2019)
Figure Europe Inflammatory Bowel Disease (IBD) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2018-2019)
Table Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2014-2019)
Table Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2014-2019)
Figure China Inflammatory Bowel Disease (IBD) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2018-2019)
Table China Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2014-2019)
Table China Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2014-2019)
Figure Japan Inflammatory Bowel Disease (IBD) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2018-2019)
Table Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2014-2019)
Table Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2018-2019)
Table Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2014-2019)
Figure India Inflammatory Bowel Disease (IBD) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2018-2019)
Table India Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2014-2019)
Table India Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2014-2019)
Figure Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2018-2019)
Table Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2014-2019)
Table Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2014-2019)
Table AbbVie Company Details
Table AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019) (Million US$)
Figure AbbVie Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Shire Plc Company Details
Table Shire Plc Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)(Million US$)
Figure Shire Plc Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
Table Shire Plc Recent Development
Table Janssen Biotech, Inc. (Johnson & Johnson) Company Details
Table Janssen Biotech, Inc. (Johnson & Johnson) Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)(Million US$)
Figure Janssen Biotech, Inc. (Johnson & Johnson) Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
Table Janssen Biotech, Inc. (Johnson & Johnson) Recent Development
Table Allergan Company Details
Table Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
Table Allergan Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)(Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Novartis Company Details
Table Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
Table Novartis Recent Development
Table Biogen Inc. Company Details
Table Biogen Inc. Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)(Million US$)
Figure Biogen Inc. Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2014-2019)
Table Biogen Inc. Recent Development
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Regions (2019-2025)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Regions in 2025
Figure United States Inflammatory Bowel Disease (IBD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Inflammatory Bowel Disease (IBD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Inflammatory Bowel Disease (IBD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Inflammatory Bowel Disease (IBD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Inflammatory Bowel Disease (IBD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Product (2019-2025)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Product in 2025
Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2019-2025)
Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の炎症性腸疾患（IBD）治療学市場：市場規模・現状・予測
    Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7361 2019年6月14日 96Pages
    当資料は、炎症性腸疾患（IBD）治療学のグローバル市場について調査・分析したレポートで、種類別（抗炎症バイオ医薬品、非ステロイド系抗炎症薬（NSAID）、コルチコステロイド）、用途別（病院、研究）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企...
  • 世界のまれな炎症性疾患の治療市場：市場規模・現状・予測
    Global Rare Inflammatory Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7937 2019年6月14日 90Pages
    当資料は、まれな炎症性疾患の治療のグローバル市場について調査・分析したレポートで、種類別（注射剤、経口、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測
    Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7488 2019年6月14日 97Pages
    当資料は、リソソーム酸リパーゼ欠乏症（LAAL）の治療のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、腎臓移植、幹細胞移植）、用途別（ウォルマン病、コレステロールエステル蓄積症（CESD））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...
  • 世界の炎症性心疾患市場：市場規模・現状・予測
    Global Inflammatory Heart Disease Market Size, Status and Forecast 2019-2025
    QYR9N7363 2019年6月14日 98Pages
    当資料は、炎症性心疾患のグローバル市場について調査・分析したレポートで、種類別（アテローム性動脈硬化、心筋炎、心膜炎）、用途別（病院と診断センター、外来サービスセンター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...
  • 世界の性感染症（STD）の治療市場：市場規模・現状・予測
    Global Sexually Transmitted Diseases (STD) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8027 2019年6月14日 97Pages
    当資料は、性感染症（STD）の治療のグローバル市場について調査・分析したレポートで、種類別（ウイルス感染、細菌感染、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の物質使用障害（SUD）の治療市場：市場規模・現状・予測
    Global Substance Use Disorders (SUDs) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8091 2019年6月14日 98Pages
    当資料は、物質使用障害（SUD）の治療のグローバル市場について調査・分析したレポートで、種類別（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存）、用途別（病院と診療所、住居（病院以外））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...
  • 世界の炎症性皮膚疾患の治療市場：市場規模・現状・予測
    Global Inflammatory Skin Diseases Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7365 2019年6月14日 97Pages
    当資料は、炎症性皮膚疾患の治療のグローバル市場について調査・分析したレポートで、種類別（レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連...
  • 世界の姿勢起立性頻脈症候群（POTS）の治療市場：市場規模・現状・予測
    Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7871 2019年6月14日 92Pages
    当資料は、姿勢起立性頻脈症候群（POTS）の治療のグローバル市場について調査・分析したレポートで、種類別（一次フォーム、二次フォーム）、用途別（病院、診療所、外来手術センター、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...
  • 世界の巣状分節性糸球体硬化症（FSGS）の治療市場：市場規模・現状・予測
    Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7216 2019年6月14日 92Pages
    当資料は、巣状分節性糸球体硬化症（FSGS）の治療のグローバル市場について調査・分析したレポートで、種類別（薬物療法、透析、腎臓移植）、用途別（一次FSGS、二次FSGS）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...